{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:24:58Z","timestamp":1793741098296,"version":"4.6.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","award":["24086"],"award-info":[{"award-number":["24086"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019971","name":"Luzhou Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019971","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.redox.2025.103813","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:56:05Z","timestamp":1754441765000},"page":"103813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Asparagine synthetase modulates glutaminase inhibitor sensitivity through metabolic reprogramming and serves as a prognostic biomarker in hepatocellular carcinoma"],"prefix":"10.1016","volume":"86","author":[{"given":"Benjian","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongning","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangnian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.redox.2025.103813_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"10360","key":"10.1016\/j.redox.2025.103813_bib2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.redox.2025.103813_bib3","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global epidemiology and genetics of hepatocellular carcinoma","volume":"164","author":"Toh","year":"2023","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.redox.2025.103813_bib4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.redox.2025.103813_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jare.2024.05.001","article-title":"Metabolic reprogramming and interventions in angiogenesis","volume":"70","author":"Liu","year":"2025","journal-title":"J. Adv. Res."},{"issue":"10","key":"10.1016\/j.redox.2025.103813_bib6","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.15252\/embj.201696151","article-title":"Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine","volume":"36","author":"Zhang","year":"2017","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.redox.2025.103813_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.513","article-title":"Redox control of glutamine utilization in cancer","volume":"5","author":"Alberghina","year":"2014","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.redox.2025.103813_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/cancers12010068","article-title":"TCA cycle rewiring as emerging metabolic signature of hepatocellular carcinoma","volume":"12","author":"Todisco","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"7858","key":"10.1016\/j.redox.2025.103813_bib9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.redox.2025.103813_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gutjnl-2024-332429","article-title":"Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A(+) myeloid cells to promote liver cancer progression","volume":"74","author":"Yang","year":"2025","journal-title":"Gut"},{"issue":"23","key":"10.1016\/j.redox.2025.103813_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233924","article-title":"Unbalanced glutamine partitioning between CD8T cells and cancer cells accompanied by immune cell dysfunction in hepatocellular carcinoma","volume":"11","author":"Chen","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.redox.2025.103813_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ebiom.2018.11.063","article-title":"Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing wnt\/beta-catenin pathway","volume":"39","author":"Li","year":"2019","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.redox.2025.103813_bib13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","article-title":"Enhancing the efficacy of Glutamine metabolism inhibitors in cancer therapy","volume":"7","author":"Yang","year":"2021","journal-title":"Trends Cancer"},{"issue":"4","key":"10.1016\/j.redox.2025.103813_bib14","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"issue":"6","key":"10.1016\/j.redox.2025.103813_bib15","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cmet.2022.04.003","article-title":"Glutaminase inhibition impairs CD8 T cell activation in STK11-\/Lkb1-deficient lung cancer","volume":"34","author":"Best","year":"2022","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.redox.2025.103813_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s43018-020-00160-x","article-title":"Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma","volume":"2","author":"Wu","year":"2021","journal-title":"Nat. Cancer"},{"issue":"4","key":"10.1016\/j.redox.2025.103813_bib17","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","article-title":"Targeting glutamine metabolism as a therapeutic strategy for cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.redox.2025.103813_bib18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56749","article-title":"A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer","volume":"9","author":"Jin","year":"2020","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.redox.2025.103813_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41421-024-00668-x","article-title":"IFRD1 promotes tumor cells \"low-cost\" survival under glutamine starvation via inhibiting histone H1.0 nucleophagy","volume":"10","author":"Huang","year":"2024","journal-title":"Cell discovery"},{"key":"10.1016\/j.redox.2025.103813_bib20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.biochem.75.103004.142520","article-title":"Asparagine synthetase chemotherapy","volume":"75","author":"Richards","year":"2006","journal-title":"Annu. Rev. Biochem."},{"issue":"7692","key":"10.1016\/j.redox.2025.103813_bib21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature25465","article-title":"Asparagine bioavailability governs metastasis in a model of breast cancer","volume":"554","author":"Knott","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.redox.2025.103813_bib22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41419-022-05015-0","article-title":"Asparagine synthetase regulates lung-cancer metastasis by stabilizing the \u03b2-catenin complex and modulating mitochondrial response","volume":"13","author":"Cai","year":"2022","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.redox.2025.103813_bib23","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1038\/emboj.2010.81","article-title":"The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation","volume":"29","author":"Ye","year":"2010","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.redox.2025.103813_bib24","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1038\/s41467-021-25079-4","article-title":"Two parallel pathways connect glutamine metabolism and mTORC1 activity to regulate glutamoptosis","volume":"12","author":"Bodineau","year":"2021","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.redox.2025.103813_bib25","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1158\/0008-5472.CAN-22-3561","article-title":"PTTG1 reprograms asparagine metabolism to promote hepatocellular carcinoma progression","volume":"83","author":"Zhou","year":"2023","journal-title":"Cancer Res."},{"issue":"W1","key":"10.1016\/j.redox.2025.103813_bib26","doi-asserted-by":"crossref","first-page":"W398","DOI":"10.1093\/nar\/gkae253","article-title":"MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation","volume":"52","author":"Pang","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.redox.2025.103813_bib27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"49","key":"10.1016\/j.redox.2025.103813_bib28","doi-asserted-by":"crossref","first-page":"19952","DOI":"10.1074\/jbc.R117.819060","article-title":"Asparagine synthetase: function, structure, and role in disease","volume":"292","author":"Lomelino","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.redox.2025.103813_bib29","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1158\/0008-5472.CAN-06-2519","article-title":"Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin","volume":"67","author":"Cui","year":"2007","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.redox.2025.103813_bib30","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1158\/0008-5472.CAN-23-2910","article-title":"Asparagine dependency is a targetable metabolic vulnerability in TP53-Altered castration-resistant prostate cancer","volume":"84","author":"Yoo","year":"2024","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.redox.2025.103813_bib31","article-title":"DDIT3 directs a dual mechanism to balance glycolysis and oxidative phosphorylation during glutamine deprivation","volume":"8","author":"Li","year":"2021","journal-title":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"11","key":"10.1016\/j.redox.2025.103813_bib32","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.tem.2017.07.003","article-title":"Surviving stress: modulation of ATF4-Mediated stress responses in normal and malignant cells","volume":"28","author":"Wortel","year":"2017","journal-title":"Trends Endocrinol. Metabol.: TEM (Trends Endocrinol. Metab.)"},{"issue":"W1","key":"10.1016\/j.redox.2025.103813_bib33","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.redox.2025.103813_bib34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nm.4232","article-title":"Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth","volume":"23","author":"Cramer","year":"2017","journal-title":"Nat. Med."},{"issue":"17","key":"10.1016\/j.redox.2025.103813_bib35","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1158\/0008-5472.CAN-21-4403","article-title":"The central role of mTORC1 in amino acid sensing","volume":"82","author":"Yue","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2025.103813_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101501","article-title":"Non-lethal sonodynamic therapy facilitates the M1-to-M2 transition in advanced atherosclerotic plaques via activating the ROS-AMPK-mTORC1-autophagy pathway","volume":"32","author":"Yang","year":"2020","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.redox.2025.103813_bib37","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.redox.2025.103813_bib38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jhep.2023.10.024","article-title":"Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism","volume":"80","author":"Zhang","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2025.103813_bib39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cbpa.2021.01.006","article-title":"Inhibition of glutaminolysis in combination with other therapies to improve cancer treatment","volume":"62","author":"Shen","year":"2021","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.redox.2025.103813_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15965","article-title":"Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism","volume":"8","author":"Biancur","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2025.103813_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102732","article-title":"Lipophagy-mediated cholesterol synthesis inhibition is required for the survival of hepatocellular carcinoma under glutamine deprivation","volume":"63","author":"Kong","year":"2023","journal-title":"Redox Biol."},{"issue":"18","key":"10.1016\/j.redox.2025.103813_bib42","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/0008-5472.CAN-22-0042","article-title":"GOT2 silencing promotes reprogramming of glutamine metabolism and sensitizes hepatocellular carcinoma to glutaminase inhibitors","volume":"82","author":"Li","year":"2022","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.redox.2025.103813_bib43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molcel.2014.08.018","article-title":"Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion","volume":"56","author":"Zhang","year":"2014","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.redox.2025.103813_bib44","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2017.12.006","article-title":"As extracellular glutamine levels decline, asparagine becomes an essential amino acid","volume":"27","author":"Pavlova","year":"2018","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.redox.2025.103813_bib45","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cmet.2022.06.010","article-title":"GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment","volume":"34","author":"Missiaen","year":"2022","journal-title":"Cell Metab."},{"issue":"23","key":"10.1016\/j.redox.2025.103813_bib46","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","article-title":"Arginine reprograms metabolism in liver cancer via RBM39","volume":"186","author":"Mossmann","year":"2023","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.redox.2025.103813_bib47","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.molcel.2022.03.016","article-title":"Filamentous GLS1 promotes ROS-induced apoptosis upon glutamine deprivation via insufficient asparagine synthesis","volume":"82","author":"Jiang","year":"2022","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.redox.2025.103813_bib48","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.redox.2025.103813_bib49","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","article-title":"mTOR signalling and cellular metabolism are mutual determinants in cancer","volume":"18","author":"Mossmann","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.redox.2025.103813_bib50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41467-017-00369-y","article-title":"Glutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation","volume":"8","author":"Tan","year":"2017","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.redox.2025.103813_bib51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41419-024-06961-7","article-title":"Stanniocalcin 2 governs cancer cell adaptation to nutrient insufficiency through alleviation of oxidative stress","volume":"15","author":"Qie","year":"2024","journal-title":"Cell Death Dis."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221323172500326X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221323172500326X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:55:58Z","timestamp":1763646958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221323172500326X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":51,"alternative-id":["S221323172500326X"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2025.103813","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asparagine synthetase modulates glutaminase inhibitor sensitivity through metabolic reprogramming and serves as a prognostic biomarker in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2025.103813","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103813"}}